Guinness Atkinson Asset Management Inc Has $5.68 Million Holdings in Danaher Corporation $DHR

Guinness Atkinson Asset Management Inc raised its stake in Danaher Corporation (NYSE:DHR) by 9.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 30,515 shares of the conglomerate’s stock after purchasing an additional 2,585 shares during the period. Danaher makes up approximately 2.7% of Guinness Atkinson Asset Management Inc’s holdings, making the stock its 20th biggest position. Guinness Atkinson Asset Management Inc’s holdings in Danaher were worth $5,678,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. WFA of San Diego LLC acquired a new position in Danaher in the 2nd quarter valued at approximately $26,000. Howard Hughes Medical Institute bought a new stake in shares of Danaher during the second quarter valued at approximately $27,000. TruNorth Capital Management LLC acquired a new position in shares of Danaher in the third quarter valued at $28,000. Tripletail Wealth Management LLC bought a new position in Danaher in the third quarter worth $31,000. Finally, Heartwood Wealth Advisors LLC acquired a new stake in Danaher during the third quarter worth $37,000. Institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

DHR has been the subject of a number of recent research reports. TD Cowen restated a “buy” rating on shares of Danaher in a research note on Wednesday, January 7th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Danaher in a research note on Thursday, January 29th. Robert W. Baird set a $251.00 price target on shares of Danaher in a research note on Thursday, January 29th. Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a research note on Saturday, November 22nd. Finally, KeyCorp reissued an “overweight” rating on shares of Danaher in a report on Thursday, January 29th. Twenty analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $252.32.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 3,298 shares of the company’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the transaction, the director owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. This represents a 13.71% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Brian W. Ellis sold 21,776 shares of Danaher stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total value of $4,773,952.48. Following the completion of the sale, the senior vice president directly owned 14,553 shares of the company’s stock, valued at $3,190,454.19. This trade represents a 59.94% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 30,248 shares of company stock worth $6,609,663. Corporate insiders own 11.10% of the company’s stock.

Danaher Price Performance

Shares of Danaher stock opened at $215.70 on Friday. The stock has a market capitalization of $152.36 billion, a price-to-earnings ratio of 42.80, a P/E/G ratio of 2.97 and a beta of 0.91. The firm’s 50-day moving average price is $229.81 and its two-hundred day moving average price is $214.68. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $242.80.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 28th. The conglomerate reported $2.23 EPS for the quarter, topping the consensus estimate of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The business had revenue of $6.84 billion for the quarter, compared to the consensus estimate of $6.79 billion. During the same period in the previous year, the business earned $2.14 EPS. Danaher’s revenue was up 4.6% compared to the same quarter last year. Danaher has set its FY 2026 guidance at 8.350-8.500 EPS. On average, equities analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, January 30th. Shareholders of record on Friday, December 26th were paid a $0.32 dividend. The ex-dividend date of this dividend was Friday, December 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s payout ratio is currently 25.40%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.